(Q34120675)

31 July 2017

title

Increased expression of elongation factor-1α is significantly correlated with poor prognosis of human prostate cancer (English)

1 reference

31 July 2017

1 reference

Huaizheng Liu

1

1 reference

31 July 2017

Jian Ding

2

1 reference

31 July 2017

Fang Chen

3

1 reference

31 July 2017

Benyi Fan

4

1 reference

31 July 2017

Ning Gao

5

1 reference

31 July 2017

Zhongqing Yang

6

1 reference

31 July 2017

Lin Qi

7

1 reference

31 July 2017

publication date

14 June 2010

1 reference

Scandinavian Journal of Urology and Nephrology

31 July 2017

published in

1 reference

31 July 2017

volume

44

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

277-283

1 reference

Watchful waiting as a treatment option for localized prostate cancer in the PSA era.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Targeted therapy of cancer: new roles for pathologists--prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Diagnosis and treatment of prostate cancer: summary of NICE guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Long-term outcome among men with conservatively treated localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

pH, EF-1alpha and the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Regulation of peptide-chain elongation in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Rat elonation factor 1α: sequence of cDNA from a highly metastatic fos-transferred cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Human elongation factor 1 alpha: a polymorphic and conserved multigene family with multiple chromosomal localizations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Elongation factor 1α, translation and the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Channeling of aminoacyl-tRNA for protein synthesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599.2010.492787

10.3109/00365599.2010.492787

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference